Unlocking cell therapies for cancer


Exogene is a biotechnology company enabling AI-powered discovery of T-cell-receptor(TCR)-based cell therapies to treat advanced solid tumours


Exogene is building a machine learning platform to rapidly find new cancer targets and rare, target-specific TCRs for cell therapy application, by comprehensively screening entire TCR repertoires derived from cancer patients. Using cutting-edge wet-lab TCR screening technologies, Exogene is able to train and validate its machine learning platform in-house by screening billions of TCR-target interactions